Low molecular weight activated protein C inhibitors as a potential treatment for hemophilic disorders

J Med Chem. 2006 Aug 24;49(17):5047-50. doi: 10.1021/jm0606950.

Abstract

The synthesis and evaluation of inhibitors of activated protein C (aPC) are reported. This serine protease is partly responsible for the degradation of factor VIIIa, involved in the regulation of bleeding in hemophilia A. Benzamidine-containing derivatives were found to be potent aPC inhibitors, some of them showing selectivity against the procoagulant protease thrombin. Moreover, compound 1 significantly restored the generation of thrombin in hemophiliac plasma.

MeSH terms

  • Benzamidines / chemistry
  • Benzamidines / pharmacology*
  • Factor VIIIa / metabolism
  • Hemophilia A / drug therapy*
  • Hemorrhage / prevention & control*
  • Humans
  • Molecular Structure
  • Molecular Weight
  • Protein C / antagonists & inhibitors*
  • Serine Proteinase Inhibitors / chemistry
  • Serine Proteinase Inhibitors / pharmacology*
  • Structure-Activity Relationship
  • Thrombin / antagonists & inhibitors
  • Thrombin / biosynthesis

Substances

  • Benzamidines
  • Protein C
  • Serine Proteinase Inhibitors
  • Factor VIIIa
  • Thrombin